Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients-Reference-Cited by-同舟云学术

Prognostic association of plasma cell-free DNA-based androgen receptor amplification and circulating tumor cells in pre-chemotherapy metastatic castration-resistant prostate cancer patients

Published:2018-06-01 Issue:3 Volume:21 Page:411-418
ISSN:1365-7852
Container-title:Prostate Cancer and Prostatic Diseases
language:en
Short-container-title:Prostate Cancer Prostatic Dis

Author:

Kohli Manish,Li Jian,Du Meijun,Hillman David W,Dehm Scott M.,Tan Winston,Carlson Rachel,Campion Michael B.,Wang Liguo,Wang Liewei,Zhang Huijuan,Zhang Peng,Kilari Deepak,Huang Chiang-Ching,Wang Liang^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Urology,Oncology

Link

http://www.nature.com/articles/s41391-018-0043-z.pdf

Reference23 articles.

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016;66:7–30.

2. Prostate Cancer Trialists Collaborative Group. Maximum androgen blockade in advanced prostate cancer: an overview of the randomised trials. Prostate Cancer Trialists’ Collaborative Group. Lancet. 2000;355:1491–8.

3. de Bono JS, Logothetis CJ, Molina A, Fizazi K, North S, Chu L, et al. Abiraterone and increased survival in metastatic prostate cancer. N Engl J Med. 2011;364:1995–2005.

4. Ryan CJ, Smith MR, de Bono JS, Molina A, Logothetis CJ, de Souza P, et al. Abiraterone in metastatic prostate cancer without previous chemotherapy. N Engl J Med. 2013;368:138–48.

5. Beer TM, Tombal B. Enzalutamide in metastatic prostate cancer before chemotherapy. N Engl J Med. 2014;371:1755–6.

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Castration-resistant prostate cancer monitoring by cell-free circulating biomarkers;Frontiers in Oncology;2024-09-10

2. Optimal systemic therapy in men with low-volume prostate cancer;Current Opinion in Urology;2024-03-05

3. Molecular biomarkers in prostate cancer tumorigenesis and clinical relevance;Critical Reviews in Oncology/Hematology;2024-02

4. Recent Advances in Blood-Based Liquid Biopsy Approaches in Prostate Cancer;The Cancer Journal;2023-07

5. Biomarkers for the Detection and Risk Stratification of Aggressive Prostate Cancer;Cancers;2022-12-11